Diligence memo · auto-generated · as of July 2, 2026

Pharmaco-Kinesis Corp

Pharmaco-Kinesis Corp looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Pharmaco-Kinesis Corp operates in Other Health Care, based in LOS ANGELES.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Pharmaco-Kinesis Corp has raised $17M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $16M on —.

Most recent recorded round closed around 2008-09-18.

Valuation (modeled)modeled

Provath models Pharmaco-Kinesis Corp at approximately $31M (range $1.1M–$242M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.07× the median modeled value of Series B Other Health Care companies in 2007–2009 (19 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 465 months.

Last raise 17.8 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 12.9× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 82% of Other Health Care peers (5377 compared).

Modeled value ranks above 58% of those peers.

Closest niche peers: Medical Imaging Holdings, Inc., ev3 Inc., Avalign Technologies Holdings, Inc., GEMCare Mercy Memorial Health System LLC, Metagenics, Inc..

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.